Propel Mometasone Furoate Implant

Propel mometasone furoate implant (trade name Propel), is a bioabsorbable steroid-eluting stent developed by Intersect ENT. It is implanted after surgery to assist in treating chronic rhinosinusitis. It delivers steroids over a 30 day period prior to dissolving, and has been shown to improve outcomes of surgery.